Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term persistence with injectable therapy in relapsing-remitting multiple sclerosis: an 18-year observational cohort study.
Zhornitsky S, Greenfield J, Koch MW, Patten SB, Harris C, Wall W, Alikhani K, Burton J, Busche K, Costello F, Davenport JW, Jarvis SE, Lavarato D, Parpal H, Patry DG, Yeung M, Metz LM. Zhornitsky S, et al. Among authors: alikhani k. PLoS One. 2015 Apr 13;10(4):e0123824. doi: 10.1371/journal.pone.0123824. eCollection 2015. PLoS One. 2015. PMID: 25867095 Free PMC article.
Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study.
Bonab MM, Sahraian MA, Aghsaie A, Karvigh SA, Hosseinian SM, Nikbin B, Lotfi J, Khorramnia S, Motamed MR, Togha M, Harirchian MH, Moghadam NB, Alikhani K, Yadegari S, Jafarian S, Gheini MR. Bonab MM, et al. Among authors: alikhani k. Curr Stem Cell Res Ther. 2012 Nov;7(6):407-14. doi: 10.2174/157488812804484648. Curr Stem Cell Res Ther. 2012. PMID: 23061813 Clinical Trial.
20 results